(13)For ethical reasons, the assessment of an active substance or a plant protection product should not be based on tests or studies involving the deliberate administration of the active substance or plant protection product to humans with the purpose of determining a human ‘no observed effect level’ of an active substance. Similarly, toxicological studies carried out on humans should not be used to lower the safety margins for active substances or plant protection products.
◷
New version applies from 30/06/2014 — introduced by Regulation (EU) No 652/2014.
60 provisions change.
Later versions: 28/08/2017, 10/11/2018, 15/07/2019, 14/12/2019, 27/03/2021, 21/11/2022, 16/06/2026.
Recital 13 changes in this version: compare with the current text.